Saroglitazar Reduced Liver Fat and Fibrosis in Metabolic Dysfunction Associated Steatotic Liver Disease: A Case Report
Asian Journal of Case Reports in Medicine and Health · pp. 93–97 · Published 9 Jul 2024
Abstract
Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) is revised nomenclature of Non-alcoholic fatty liver disease (NAFLD) which is very commonly prevalent condition in India. Currently only one drug Saroglitazar is approved for treatment of NAFLD in India. It is a dual peroxisome proliferator-activated receptor (PPAR α/γ) agonist which improves insulin sensitivity and reduce triglyceride along with liver fat and fibrosis in NAFLD cases. In this case study, MASLD patient was prescribed Saroglitazar 4 mg once daily along with existing anti-diabetic and lipid lowering therapy and at 24 weeks; Saroglitazar had shown significant improvement in glycemic, lipid and transient elastography parameters.
Cited by 0
No indexed citations yet.
Related research
- Clinical Case Series on Assessment of Therapeutic Efficacy of Saroglitazar in MASLD Patients — shares topic coverage
- Interrelationship between Non-Alcoholic Steatohepatitis and Vitamin D: A Mini Review — shares topic coverage
- Identifying Possible Hepatic Fibrosis of Hepatitis B Origin Using Non-invasive Markers: A Case-control Study in the South West Region of Cameroon — shares topic coverage
- Circulating Survivin and TIMP-1 in Hepatitis C Virus Associated Liver Fibrosis — shares topic coverage
- Effect of Lycopene and Genistein on Hepatic Inflammation and Fibrosis in Thioacetamide Induced Liver Injury in Rats — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.